These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 24862107

  • 1. Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer.
    Mahal BA, Ziehr DR, Aizer AA, Hyatt AS, Lago-Hernandez C, Choueiri TK, Elfiky AA, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Kim SP, Lathan CS, Trinh QD, Nguyen PL.
    J Geriatr Oncol; 2014 Oct 01; 5(4):352-8. PubMed ID: 24862107
    [Abstract] [Full Text] [Related]

  • 2. Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer.
    Mahal BA, Ziehr DR, Aizer AA, Hyatt AS, Sammon JD, Schmid M, Choueiri TK, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Lathan C, Kim SP, Trinh QD, Nguyen PL.
    Urol Oncol; 2014 Nov 01; 32(8):1285-91. PubMed ID: 24846344
    [Abstract] [Full Text] [Related]

  • 3. Income inequality and treatment of African American men with high-risk prostate cancer.
    Ziehr DR, Mahal BA, Aizer AA, Hyatt AS, Beard CJ, D Amico AV, Choueiri TK, Elfiky A, Lathan CS, Martin NE, Sweeney CJ, Trinh QD, Nguyen PL.
    Urol Oncol; 2015 Jan 01; 33(1):18.e7-18.e13. PubMed ID: 25306287
    [Abstract] [Full Text] [Related]

  • 4. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O, Ikuemonisan J, Salami SS, Adejoro O.
    J Racial Ethn Health Disparities; 2019 Apr 01; 6(2):401-408. PubMed ID: 30506310
    [Abstract] [Full Text] [Related]

  • 5. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K, Lee KM, Awasthi S, Alba PR, Perez C, Anglin-Foote TR, Robison B, Gao A, DuVall SL, Katsoulakis E, Wong YN, Markt SC, Rose BS, Burri R, Wang C, Aboiralor O, Fink AK, Nickols NG, Lynch JA, Garraway IP.
    JAMA Netw Open; 2022 Jan 04; 5(1):e2144027. PubMed ID: 35040965
    [Abstract] [Full Text] [Related]

  • 6. Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insurance.
    Mahal AR, Mahal BA, Nguyen PL, Yu JB.
    Cancer; 2018 Feb 15; 124(4):752-759. PubMed ID: 29084350
    [Abstract] [Full Text] [Related]

  • 7. Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups.
    Mahal BA, Aizer AA, Ziehr DR, Hyatt AS, Sammon JD, Schmid M, Choueiri TK, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Kim SP, Trinh QD, Nguyen PL.
    Urology; 2014 Aug 15; 84(2):386-92. PubMed ID: 24975710
    [Abstract] [Full Text] [Related]

  • 8. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.
    Shavers VL, Brown ML, Potosky AL, Klabunde CN, Davis WW, Moul JW, Fahey A.
    J Gen Intern Med; 2004 Feb 15; 19(2):146-55. PubMed ID: 15009794
    [Abstract] [Full Text] [Related]

  • 9. Effect of type of definitive treatment on race-based differences in prostate cancer-specific survival.
    Frego N, Labban M, Stone BV, Koelker M, Alkhatib K, Lughezzani G, Buffi NM, Lipsitz SR, Weissman JS, Fletcher SA, Kibel AS, Trinh QD, Cole AP.
    Prostate; 2023 Aug 15; 83(11):1099-1111. PubMed ID: 37150867
    [Abstract] [Full Text] [Related]

  • 10. Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancer.
    Mahal BA, Aizer AA, Ziehr DR, Hyatt AS, Choueiri TK, Hu JC, Hoffman KE, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Kim SP, Trinh QD, Nguyen PL.
    Clin Genitourin Cancer; 2014 Oct 15; 12(5):e189-95. PubMed ID: 24861952
    [Abstract] [Full Text] [Related]

  • 11. Disparities in treatment patterns and mortality in prostate cancer: Interaction between Black race and end-stage kidney disease.
    Sarabu N, Dong W, Koroukian SM.
    Cancer Med; 2024 May 15; 13(10):e7027. PubMed ID: 38770622
    [Abstract] [Full Text] [Related]

  • 12. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
    Kelly SP, Rosenberg PS, Anderson WF, Andreotti G, Younes N, Cleary SD, Cook MB.
    Eur Urol; 2017 Feb 15; 71(2):195-201. PubMed ID: 27476048
    [Abstract] [Full Text] [Related]

  • 13. African-American Men with Low-Risk Prostate Cancer: Modern Treatment and Outcome Trends.
    Obirieze AC, Moten A, Allen D, Ahaghotu CA.
    J Racial Ethn Health Disparities; 2015 Sep 15; 2(3):295-302. PubMed ID: 26863460
    [Abstract] [Full Text] [Related]

  • 14. A Population-Based Study of Men With Low-Volume Low-Risk Prostate Cancer: Does African-American Race Predict for More Aggressive Disease?
    Schreiber D, Chhabra A, Rineer J, Weedon J, Schwartz D.
    Clin Genitourin Cancer; 2015 Aug 15; 13(4):e259-e264. PubMed ID: 25777681
    [Abstract] [Full Text] [Related]

  • 15. Association of Health-Care System With Prostate Cancer-Specific Mortality in African American and Non-Hispanic White Men.
    Klebaner D, Courtney PT, Garraway IP, Einck J, Kumar A, Martinez ME, McKay R, Murphy JD, Parada H, Sandhu A, Stewart T, Yamoah K, Rose BS.
    J Natl Cancer Inst; 2021 Oct 01; 113(10):1343-1351. PubMed ID: 33892497
    [Abstract] [Full Text] [Related]

  • 16. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort.
    Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W.
    Cancer; 2006 Mar 15; 106(6):1276-85. PubMed ID: 16475208
    [Abstract] [Full Text] [Related]

  • 17. Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States.
    Mahal BA, Chen YW, Muralidhar V, Mahal AR, Choueiri TK, Hoffman KE, Hu JC, Sweeney CJ, Yu JB, Feng FY, Kim SP, Beard CJ, Martin NE, Trinh QD, Nguyen PL.
    Ann Oncol; 2017 May 01; 28(5):1098-1104. PubMed ID: 28453693
    [Abstract] [Full Text] [Related]

  • 18. Racial differences in time from prostate cancer diagnosis to treatment initiation: a population-based study.
    Stokes WA, Hendrix LH, Royce TJ, Allen IM, Godley PA, Wang AZ, Chen RC.
    Cancer; 2013 Jul 01; 119(13):2486-93. PubMed ID: 23716470
    [Abstract] [Full Text] [Related]

  • 19. Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
    Barrington WE, Schenk JM, Etzioni R, Arnold KB, Neuhouser ML, Thompson IM, Lucia MS, Kristal AR.
    JAMA Oncol; 2015 Jun 01; 1(3):342-9. PubMed ID: 26181184
    [Abstract] [Full Text] [Related]

  • 20. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
    Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, Fahey A.
    Med Care; 2004 Mar 01; 42(3):239-50. PubMed ID: 15076823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.